Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minirin Versus Oxybutynin for Nocturnal Enuresis in Children
NCT02538302Phase 3Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Jul 2013
- Primary completion
- Jul 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of desmopressin in nocturnal enuresis (NE) (2 arms), sponsored by Hormozgan University of Medical Sciences. Primary endpoint: Frequency of nocturnal enuresis at 6 months. Started Jul 2013; status: completed.
02
Drugs
desmopressin
03
Conditions
nocturnal enuresis (NE)
Beyond the preview
Go deeper on NCT02538302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02538302.